Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease

Nature Medicine

Volumn 2, Issue 11, 1996, Pages 1230-1235

  Kennard, Malcolm L ^a   Feldman, Howard ^a   Yamada, Tatsuo ^b   Jefferies, Wilfred A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; IRON BINDING PROTEIN; TRANSFERRIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN STABILITY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CARRIER PROTEINS; FEMALE; HUMANS; IRON-BINDING PROTEINS; MALE; MIDDLE AGED; TRANSFERRIN; TRANSFERRIN-BINDING PROTEINS;

EID: 0029955035     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1196-1230     Document Type: Article

References (46)

1. Goedert, M., Spillantini, M.G., Cairns, N.J. & Crowther, R.A. Tau protein of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 8, 156-160 (1992).
2. Selkoe, D.J. The molecular pathology of Alzheimer's disease. Neuron 6, 487-498 (1991).
3. Terry, R.D., Masliah, E. & Salmon, D.P. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580 (1991).
4. Blass, J.P. Pathophysiology of Alzheimer's syndrome. Neurology 43, S25-38 (1993).
5. McKhann, G. et al. Clinical diagnosis of Alzheimer's disease - Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944 (1984).
6. Shoji, M. et al. Production of the Alzheimer amyloid beta protein by normal proteolytic cleavage. Science 258, 126-129 (1992).
7. Nakamura, T. et al. Amyloid β protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease. Ann. Neurol. 36, 903-911 (1994).
8. Roher, A.E. et al. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268, 3072-3083 (1993).
9. 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann. Neurol. 38, 643-648 (1995).
10. Van Nostrand, W.E. et al. Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer patients. Proc. Natl. Acaid. Sci. USA 89, 2551-2555 (1992).
11. Palmert, M.R. et al. Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid. Neurol. 40, 1028-1034 (1990).
12. Kitaguchi, N. et al. Determination of amyloid beta protein precursors harboring active form of protease inhibitor domains in cerebrospinal fluid in Alzheimer's disease patients by a trypsin antibody sandwich ELISA. Biochem. Biophys. Res. Commun 166, 1453-1459 (1990).
13. Vigo-Pelfrey, C. et al. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology 45, 788-793 (1995).
14. Vandermeeren, M. et al. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J. Neurochem. 61, 1828-1834 (1993).
15. Abraham, C.R., Selkoe, D.J. & Potter, H. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52, 487-501 (1988).
16. Wang, G.P. et al. Alzheimer's disease: Paired helical filament immunoreactivity in cerebrospinal fluid. Acta Neuropathol. (Berl.) 82, 6-12 (1991).
17. Sanders, A.M. et al. Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Nurology 43, 1467-1472 (1993).
18. Murrell, J., Farlow, M., Ghetti, B. & Benson, M.D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97-99 (1991).
19. Karlinsky, H. et al. Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation of codon of the beta amyloid precursor protein gene. Neurology 42, 1445-1453 (1992).
20. Schellenberg, G.D. et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258, 668-671 (1992).
21. Sherrington, R. et al. Cloning of a gene bearing missense mutations in the early onset of familial Alzheimer's disease. Nature 375, 754-760 (1995).
22. Levy-Lahad, E. et al. Candidate genes for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977 (1995).
23. Rogaev, E.I. et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to Alzheimer's disease type 3 gene. Nature 376, 775-778 (1995).
24. Strittmatter, W.J. et al. Apolipoprotein E: High avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981 (1993).
25. Brown, J.P., Nishiyama, K., Hellström, I. & Hellström, K.E. Structural characterization of human-melanoma-associated antigen p97 with monoclonal antibodies. J. Immunol. 127, 539-546 (1981).
26. Baker, E.N., Rumball, S.V. & Anderson, B.F. Transferrins: Insights into structure and function from studies on Iactoferrin. Trends Biochem. Sci. 12, 350-353 (1987).
27. Kennard, M.L., Richardson, D.R., Gabathuler, R., Ponka, P. & Jefferies, W.A. A novel iron uptake mechanism mediated by GPI-anchored human p97. EMBO J. 14, 4178-4186 (1995).
28. Food, M.R. et al. Transport and expression in human melanomas of a transferrinlike glycosylphospatidylinositol-anchored protein. J. Biol. Chem. 269, 3034-3040 (1994).
29. Rothenberger, S. et al. Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium. Brain Res. 712, 117-121 (1996).
30. Jefferies, W.A. et al. Reactive microglia specifically associated with amyloid plaques in Alzheimer's discase express melanotransferrin. Brain Res. 712, 122-126 (1996).
31. Kennard, M.L., Food, M.R., Jefferies, W.A. & Piret, J.M. Controlled process to recover heterologous glycosylphosphatidylinositol membrane anchored proteins from CHO cells. Biotech. Bioeng. 42, 480-486 (1993).
32. Brown, J.P., Woodbury, R.G., Hart, C.E., Hellström, I. & Hellström, K.E. Quantitative analysis of melanoma-associated antigen p97 in normal neoplastic tissues. Proc. Natl. Acad. Sci. USA 78, 539-543 (1981).
33. Connor, J.R., Menzies, S.L., St. Martin, S.M. & Mufson, E.J. A histochemical study of iron, transferrin and ferritin in Alzheimer's disease brains. J. Neurosci. Res. 31, 75-83 (1992).
34. Gerlach, M., Ben-Shachar, D., Riederer, P. & Youdim, M.B.H. Altered brain metabolism of iron as a cause of neurodegenerative diseases. J. Neurochem. 63, 793-807 (1994).
35. Multhaup, G. et al. The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I). Science 271, 1406-1409 (1996).
36. Dedman, D.J. et al. Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's disease and chronic real-dialysis patients. Biochem. J. 287, 509-514 (1992).
37. Mantyh, P.W. et al. Aluminum, iron and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J. Neurochem. 61, 1171-1174 (1993).
38. Bush, A.I. et al. Zinc and Alzheimer's disease. Science 268, 1921-1922 (1995).
39. Ehmann, W.D. et al. Brain trace elements in Alzheimer's disease. Neurotoxicology 7, 195-206 (1986).
40. Robinson, S.R., Noone, D.F., Kril, J. & Halliday, G.M. Most amyloid plaques contain ferritin rich cells. Alzheimer's Res. 1, 191-196 (1996).
41. Grundke-Iqbal, I et al. Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathalogica. 81, 105-110 (1990).
42. Good, P.F., Perl, D.P., Bierer, L.M. & Schmeidler, J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease. Ann. Neurol. 31, 286-292 (1992).
43. McLachlan, D.R.C. et al. Intramuscular desferroxamine in patients with Alzheimer's disease. Lancet 337, 1304-1308 (1991).
44. Bodovitz, S., Faltudo, M.T., Frail, F.E. & Klein, W.L. Iron levels modulate alpha-secretase cleavage of amyloid precursor protein. J. Neurochem. 64, 307-315 (1995).
45. Zubenko, G.S. et al. Clinically silent mutation in the putative iron-response element in exon 17 of the beta-amyloid precursor protein gene. J. Neuropathol. Exp. Neurol. 51, 459-463 (1992).
46. Jolley, M. et al. Particle concentration fluorescence immunoassay (PCFIA): A new rapid immunoassay technique with high sensitivity. J. Immunol. Methods 67, 21-35 (1984).